Dow Jones

38,798.99

-0.22%

Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

Regístrate

GTBP

GT Biopharma (GTBP)

GT Biopharma Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:GTBP

1 2 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
07/06/2024	16:25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GTBP	GT Biopharma Inc
23/05/2024	19:31	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:GTBP	GT Biopharma Inc
23/05/2024	05:04	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:GTBP	GT Biopharma Inc
15/05/2024	16:00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:GTBP	GT Biopharma Inc
06/11/2023	16:25	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:GTBP	GT Biopharma Inc
06/11/2023	16:21	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:GTBP	GT Biopharma Inc
27/10/2023	16:23	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:GTBP	GT Biopharma Inc
19/09/2023	10:56	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:GTBP	GT Biopharma Inc
15/08/2023	18:29	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GTBP	GT Biopharma Inc
05/05/2023	16:30	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:GTBP	GT Biopharma Inc
05/05/2023	16:29	Edgar (US Regulatory)	Revised Proxy Soliciting Materials (definitive) (defr14a)	NASDAQ:GTBP	GT Biopharma Inc
04/05/2023	18:15	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:GTBP	GT Biopharma Inc
04/05/2023	08:06	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:GTBP	GT Biopharma Inc
11/04/2023	18:00	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GTBP	GT Biopharma Inc
30/03/2023	16:02	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:GTBP	GT Biopharma Inc
14/02/2023	11:55	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:GTBP	GT Biopharma Inc
04/01/2023	05:02	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:GTBP	GT Biopharma Inc
21/10/2022	05:04	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:GTBP	GT Biopharma Inc
13/09/2022	05:20	TipRanks	Analysts Offer Insights on Healthcare Companies: Dynavax (DVAX), Ascendis Pharma (ASND) and GT Biopharma (GTBP)	NASDAQ:GTBP	GT Biopharma Inc
17/08/2022	16:01	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:GTBP	GT Biopharma Inc
15/08/2022	08:38	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:GTBP	GT Biopharma Inc
25/07/2022	15:36	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:GTBP	GT Biopharma Inc
19/05/2022	10:45	TipRanks	B.Riley Financial Thinks GT Biopharma’s Stock is Going to Recover	NASDAQ:GTBP	GT Biopharma Inc
29/04/2022	16:21	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:GTBP	GT Biopharma Inc
19/04/2022	16:31	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:GTBP	GT Biopharma Inc
12/04/2022	05:26	TipRanks	GT Biopharma (GTBP) Receives a Buy from H.C. Wainwright	NASDAQ:GTBP	GT Biopharma Inc
11/03/2022	05:28	TipRanks	H.C. Wainwright Sticks to Its Buy Rating for GT Biopharma (GTBP)	NASDAQ:GTBP	GT Biopharma Inc
03/03/2022	05:07	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:GTBP	GT Biopharma Inc
29/12/2021	16:26	Edgar (US Regulatory)	Amended Quarterly Report (10-q/a)	NASDAQ:GTBP	GT Biopharma Inc
23/08/2021	06:00	PR Newswire (US)	GT Biopharma Announces the Promotion of Dr. Gregory Berk to President of Research & Development and Chief Medical Officer	NASDAQ:GTBP	GT Biopharma Inc